Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
The current Abbott(ABT) stock price is $126.19, with a market capitalization of 219.43B. The stock trades at a price-to-earnings (P/E) ratio of 16.11 and offers a dividend yield of 1.8%.
On 2025-12-17, Abbott(ABT) stock traded between a low of $125.94 and a high of $127.67. Shares are currently priced at $126.19, which is +0.2% above the low and -1.2% below the high.
The Abbott(ABT)'s current trading volume is 2.26M, compared to an average daily volume of 5.65M.
During the past year, Abbott(ABT) stock moved between $110.86 at its lowest and $141.23 at its peak.
During the past year, Abbott(ABT) stock moved between $110.86 at its lowest and $141.23 at its peak.
ABT News
These stocks will pay you just for owning them. When the market is roaring higher as it's been doing over the past three years, it's easy to forget about the i...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor m...
Analyst ratings
68%
of 31 ratingsMore ABT News
Abbott (ABT) announced that its board of directors has increased the company’s quarterly common dividend to 63c per share, an increase of 6.8%. The cash dividen...
In early December 2025, Abbott announced that its Lingo over-the-counter continuous glucose monitor became available for Android users, while new real-world dat...
